Your browser doesn't support javascript.
loading
Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16.
Yasui, H; Okita, Y; Nakamura, M; Sagawa, T; Watanabe, T; Kataoka, K; Manaka, D; Shiraishi, K; Akazawa, N; Okuno, T; Shimura, T; Shiozawa, M; Sunakawa, Y; Ota, H; Kotaka, M; Okuyama, H; Takeuchi, M; Ichikawa, W; Fujii, M; Tsuji, A.
Affiliation
  • Yasui H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe.
  • Okita Y; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kita-gun.
  • Nakamura M; Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto.
  • Sagawa T; Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo.
  • Watanabe T; Department of Surgery, Japanese Red Cross Society Himeji Hospital, Himeji.
  • Kataoka K; Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya.
  • Manaka D; Department of Surgery, Gastro-Intestinal Center, Kyoto Katsura Hospital, Kyoto.
  • Shiraishi K; Department of Medical Oncology, National Hospital Organization Nagoya Medical Center, Nagoya.
  • Akazawa N; Department of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, Sendai.
  • Okuno T; Department of Medical Oncology, Osaka Rosai Hospital, Sakai.
  • Shimura T; Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya.
  • Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama.
  • Sunakawa Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki.
  • Ota H; Department of Gastroenterological Surgery, Ikeda City Hospital, Ikeda.
  • Kotaka M; Gastrointestinal Cancer Center, Sano Hospital, Kobe.
  • Okuyama H; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kita-gun.
  • Takeuchi M; Graduate School of Mathematical Sciences, The University of Tokyo, Meguro-ku.
  • Ichikawa W; Division of Medical Oncology, Showa University Fujigaoka Hospital, Yokohama.
  • Fujii M; Department of Digestive Surgery, Nihon University School of Medicine, Itabashi-ku, Japan.
  • Tsuji A; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kita-gun. Electronic address: tsuji.akihito@kagawa-u.ac.jp.
ESMO Open ; 8(5): 101636, 2023 10.
Article in En | MEDLINE | ID: mdl-37703596

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Colonic Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: ESMO Open Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Colonic Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: ESMO Open Year: 2023 Type: Article